companyprofile

Actions

Qomel Co.

9600
QOMEL
Add To Watchlist
In your Watchlist
Add To Watchlist
  • Main Market
  • Health Care Equipment & Svc

Stats Overview

  • Prev. Close -
  • Open N/A
  • High
  • Low
  • No. of Trades
  • Avg. Trade size* N/A
  • Volume Traded
  • Value Traded (SAR)

Performance

QOMEL
- ( - )
Compare
Name Price Change %
Qomel Co. %
Note: Prices are delayed minimum 5 minutes
  • *Average Trade Size = Cumulative / # of Trades
  • **52 Week Price Change =   (Current Price - Price year ago) / Price year ago x 100
  • Historical prices & volume traded data are adjusted to account for all corporate actions.
  • MO: Market Order

Trade Updates

Last Trade

Price
-
% Change
-
Volume Traded
0

Best Bid

Price -
Volume -

Best Offer

Price -
Volume -

52 WEEK

High
107.00
2024/05/14
Low
74.00
2024/05/26
Change**
0.0

PERFORMANCE

Start of Year
Year ago
3 Years ago

Compare Selected

Select a Maximum of 5 Companies

Compare Selected

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions

Add to watchlist

AnnouncmentandCorporateAction

Actions
Jump To :
  • Announcements & Corporate Actions
  • Dividends
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Announcements

  • Correction announcement from Qomel Co. in regards to resignation and appointment of a board member

    9600
    QOMEL -3.85 %
    1445/11/18     26/05/2024 08:15:42
  • Qomel Co. Announces Resignation and Appointment of a Board Member

    9600
    QOMEL -3.85 %
    1445/11/15     23/05/2024 08:03:25
View All

Corporate Actions

Upcoming Events

    Past Events

      Jump To :
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Dividends

      Announced Date Eligibility Date Distribution Date Distribution Way Dividend Amount

      CompanyProfilev2Financials

      Actions
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Financials

      • FINANCIAL INFORMATION
      • FINANCIAL STATEMENTS AND REPORTS
      • Annually
      • Quarterly
      Balance Sheet 2023-12-31
      Total Assets
      99,119
      - - -
      Total Liabilities
      53,616
      - - -
      Total Shareholders Equity (After Deducting the Minority Equity)
      45,502
      - - -
      Total Liabilities and Shareholders Equity
      99,119
      - - -
      Statement of Income 2023-12-31
      Total Revenue (Sales/Operating)
      105,473
      - - -
      Net Profit (Loss) before Zakat and Tax
      19,037
      - - -
      Zakat and Income Tax
      -1,443
      - - -
      Net Profit (Loss) after Zakat and Tax
      17,594
      - - -
      Total Comprehensive Income
      17,512
      - - -
      Profit (Loss) per Share
      5.86
      - - -
      Cash Flow 2023-12-31
      Net Cash From Operating Activities
      -4,397
      - - -
      Net Cash From Investing Activities
      -12,034
      - - -
      Net Cash From Financing Activities
      2,402
      - - -
      Cash and Cash Equivalents, Beginning of the Period
      25,405
      - - -
      Cash and Cash Equivalents, End of the Period
      11,376
      - - -
      All Figures in Thousands
      All Currency In SAR
      Last Update Date 2024-05-22

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Balance Sheet
      Total Assets
      Total Liabilities
      Total Shareholders Equity (After Deducting the Minority Equity)
      Total Liabilities and Shareholders Equity
      Statement of Income
      Total Revenue (Sales/Operating)
      Net Profit (Loss) before Zakat and Tax
      Zakat and Income Tax
      Net Profit (Loss) after Zakat and Tax
      Total Comprehensive Income
      Profit (Loss) per Share
      Cash Flow
      Net Cash From Operating Activities
      Net Cash From Investing Activities
      Net Cash From Financing Activities
      Cash and Cash Equivalents, Beginning of the Period
      Cash and Cash Equivalents, End of the Period
      All Figures in
      All Currency In
      Last Update Date

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Display Previous Periods
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Shareholding Information

      • Board Of Directors
      • Foreign Ownership
      • Substantial Shareholders
      Time Period
      -
      Search
      Trading Date Shareholders Designation Shares Held Trading Day Shares Held Prev Trading Day Change
      2024-05-30 بندر عبدالرحمن محمد النمر Board of Directors 20.5714286% 20.5714286% 0
      2024-05-30 هشام عبدالله محمد العقلاء Senior Executives 17.1428571% 17.1428571% 0
      2024-05-30 هشام عبدالله محمد العقلاء Board of Directors 17.1428571% 17.1428571% 0
      • The listed company (Publisher) shall be responsible for the accuracy of the published information pertaining to the ownership of the Board of Directors, Chief Executive Officer or highest executive position, and the Chief Financial Officer. The listed company shall also be responsible for updating these information thereof. Therefore, the Saudi Stock Exchange (Tadawul) shall not be liable for the information contained therein, nor for any consequences that may result from the said information.
      for
      subs
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Peer Comparison

      • Table
      • Graphical
      Add Company

      Compare Selected

      Select a Maximum of 5 Companies

      Company Apply
      Qomel Co.
      Price -
      Market Cap (SAR MN)
      P/E Ratio -
      Index Name Index Level 1D Return
      Qomel Co. %
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Company Profile

      Company overview

      Qomel Company offers a variety of services in the healthcare sector, including pharmaceuticals and medical rehabilitation. We currently have distribution agreements with multinational companies for specialized medications and medical devices.

      Company History

      Qomel Company was established in 2007 as a limited liability healthcare company headquartered in Riyadh, Saudi Arabia, with sales offices in Jeddah and Dammam. Additionally, it has three warehouses equipped with state-of-the-art technologies and compliant with the requirements of the Saudi Food and Drug Authority in Riyadh, Dammam, and Jeddah. Qomel obtained all necessary licenses for trading pharmaceuticals and medical supplies in late 2007, with the establishment of a main office and warehouse in Riyadh. Business operations commenced in early 2008

      Company Bylaws

      Click here

      Equity Profile

      • Authorized Capital (SAR) 35,000,000
      • Issued Shares 3,500,000
      • Paid Capital (SAR) 35,000,000
      • Par Value/Share 10
      • Paid Up Value/Share 10

      Last Update :2024-05-08

      Investment limits

      There are no restrictions on the company's shares as stated in both the regulations governing the investment of qualified foreign financial institutions in listed securities and the instructions regulating the ownership of strategic stakes by foreign strategic investors in listed companies, in accordance with the company's articles of association and the instructions issued by the supervisory and regulatory authorities to which the company is subject to.

       

      • Company Details
      • BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
      • Date Established

        2007/07/13

      • Financial Year End

        31/12

      • Listing Date

        2024/05/09

      • External Auditors

        [RSM]

      • ISIN CODE

        SA162184M018

      • Number of Employees

        39

      • Chairman

        Nasser Abdulaziz Almubarak
        Non - Executive

        Nasser Abdulaziz Almubarak
        • BD Session Start
          2023-04-04
          Designation
          Chairman
        • BD Session End
          2027-04-04
          Classification
          Non - Executive
        • Qualification
          Ph.d in Urban Planning Master's degree in architecture -
      • Board of Directors

        Bandar Abdulrahman Alnamer Deputy Chairman - Non Executive

        Bandar Abdulrahman Alnamer
        • BD Session Start
          2023-04-04
          Designation
          Board of Directors
        • BD Session End
          2027-04-04
          Classification
          Deputy Chairman - Non Executive
        • Qualification
          Master's degree in career specialization Bachelor of Arts
        Companies Membership
        • Memebrship Name
          Saudi Ejab Contracting Company
          Start Date
          2023-01-01
        • Memebrship Character
          Managing Board Director
          End Date
          2027-01-01

        Sultan Abdulaziz Almubarak Non - Executive

        Sultan Abdulaziz Almubarak
        • BD Session Start
          2023-04-04
          Designation
          Board of Directors
        • BD Session End
          2027-04-04
          Classification
          Non - Executive
        • Qualification
          Ph.D. in bodily diseases and its relationship to oral infections Master's degree in dental root membrane Bachelor's degree in dentistry
        Companies Membership
        • Memebrship Name
          Jazan Development and Investment Co.
          Start Date
          2022-04-13
        • Memebrship Character
          Chairman
          End Date
          2025-04-13

        Hisham Abdullah Alagla Executive

        Hisham Abdullah Alagla
        • BD Session Start
          2023-04-04
          Designation
          Board of Directors
        • BD Session End
          2027-04-04
          Classification
          Executive
        • Qualification
          Bachelors in Pharmacy Marketing Diploma

        Hamad Abdllah Almanea Non - Executive

        Hamad Abdllah Almanea
        • BD Session Start
          2024-05-22
          Designation
          Board of Directors
        • BD Session End
          2027-04-04
          Classification
          Non - Executive
        • Qualification
          Doctorate Degree in Otolaryngology Specialization Certificate in Otolaryngology Bachelor in Medicine and Medicine
      • Senior Executives

        Hisham Abdullah Alagla CEO

        Hisham Abdullah Alagla
        • BD Session Start
          2023-01-01
          Designation
          Senior Executives
        • BD Session End
          -
          Classification
          CEO
        • Qualification
          Bachelors in Pharmacy Marketing Diploma

        Sherif Mohamed Ahmed Elsayegh CFO

      Sherif Mohamed Ahmed Elsayegh
      • BD Session Start
        2024-01-01
        Designation
        Senior Executives
      • BD Session End
        -
        Classification
        CFO
      • Qualification
        Bachelor in Accounting

      Investor Relations

      Contact Name:

      Alanoud Yousef Alomani

      Company Address:

      Al Safwah Commercial Center, Gate # 4, Office # 4107, Sulaymaniyah District, P.O. Box 19811, Riyadh 11445, Saudi Arabia

      Contact Details:

      Telephone: 00966112886660
      Fax : 00966112886668
      Email : info@qomel.com

      Company Website:

      www.qomel.com


      Add To Watchlist
      In your Watchlist
      Add To Watchlist

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.